 | • レポートコード：MRC2102QY11995 • 出版社/出版日： / 2021年1月 • レポート形態：英文、PDF、141ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医療機器 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,184,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYリサーチ社の本調査レポートでは、世界の核医学における放射性医薬品市場について種類別（診断用放射性医薬品、治療用放射性医薬品、濃縮安定同位体）、用途別（診断、治療、研究、製薬、工業）、地域別（米国、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・核医学における放射性医薬品市場の概要 ・世界の主要地域別核医学における放射性医薬品市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の核医学における放射性医薬品市場規模2015-2026：種類別（診断用放射性医薬品、治療用放射性医薬品、濃縮安定同位体） ・世界の核医学における放射性医薬品市場規模2015-2026：用途別（診断、治療、研究、製薬、工業） ・核医学における放射性医薬品の米国市場規模2015-2020 ・核医学における放射性医薬品のヨーロッパ市場規模2015-2020 ・核医学における放射性医薬品の中国市場規模2015-2020 ・核医学における放射性医薬品の日本市場規模2015-2020 ・核医学における放射性医薬品の東南アジア市場規模2015-2020 ・核医学における放射性医薬品のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・核医学における放射性医薬品の製造コスト分析 ・販売チャネル、流通業者、顧客 ・核医学における放射性医薬品の市場動向・機会・課題 ・調査の結論 |
Market Analysis and Insights: Global Radiopharmaceuticals in Nuclear Medical Market
The global Radiopharmaceuticals in Nuclear Medical market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
Global Radiopharmaceuticals in Nuclear Medical Scope and Market Size
The global Radiopharmaceuticals in Nuclear Medical market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Radiopharmaceuticals in Nuclear Medical market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.
Segment by Type, the Radiopharmaceuticals in Nuclear Medical market is segmented into
Diagnostic Radiopharmaceuticals
Therapy Radiopharmaceuticals
Enriched Stable Isotopes
Segment by Application, the Radiopharmaceuticals in Nuclear Medical market is segmented into
Diagnostic Application
Therapeutic Application
Research
Pharmaceutical
Industrial
The Radiopharmaceuticals in Nuclear Medical market is analysed and market size information is provided by regions (countries). Segment by Application, the Radiopharmaceuticals in Nuclear Medical market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Radiopharmaceuticals in Nuclear Medical Market Share Analysis
Radiopharmaceuticals in Nuclear Medical market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Radiopharmaceuticals in Nuclear Medical business, the date to enter into the Radiopharmaceuticals in Nuclear Medical market, Radiopharmaceuticals in Nuclear Medical product introduction, recent developments, etc.
The major vendors covered:
Bracco Imaging
Cambridge Isotope Laboratories
Cardinal Health
Medtronic
Eczacibasi-Monrol
Fujifilm Holdings Corporation
GE Healthcare (Subsidiary Of General Electric Company)
IBA Group
Lantheus Medical Imaging
Nordion
Ntp Radioisotopes
Siemens Healthcare
Taiyo Nippon Sanso Corporation
Urenco Limited
Rotem Industries
1 Radiopharmaceuticals in Nuclear Medical Market Overview
1.1 Radiopharmaceuticals in Nuclear Medical Product Scope
1.2 Radiopharmaceuticals in Nuclear Medical Segment by Type
1.2.1 Global Radiopharmaceuticals in Nuclear Medical Sales by Type (2020-2026)
1.2.2 Diagnostic Radiopharmaceuticals
1.2.3 Therapy Radiopharmaceuticals
1.2.4 Enriched Stable Isotopes
1.3 Radiopharmaceuticals in Nuclear Medical Segment by Application
1.3.1 Global Radiopharmaceuticals in Nuclear Medical Sales Comparison by Application (2020-2026)
1.3.2 Diagnostic Application
1.3.3 Therapeutic Application
1.3.4 Research
1.3.5 Pharmaceutical
1.3.6 Industrial
1.4 Radiopharmaceuticals in Nuclear Medical Market Estimates and Forecasts (2015-2026)
1.4.1 Global Radiopharmaceuticals in Nuclear Medical Sales Growth Rate (2015-2026)
1.4.2 Global Radiopharmaceuticals in Nuclear Medical Revenue and Growth Rate (2015-2026)
1.4.3 Global Radiopharmaceuticals in Nuclear Medical Price Trends (2015-2026)
2 Radiopharmaceuticals in Nuclear Medical Estimate and Forecast by Region
2.1 Global Radiopharmaceuticals in Nuclear Medical Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Radiopharmaceuticals in Nuclear Medical Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Radiopharmaceuticals in Nuclear Medical Sales Market Share by Region (2015-2020)
2.2.2 Global Radiopharmaceuticals in Nuclear Medical Revenue Market Share by Region (2015-2020)
2.3 Global Radiopharmaceuticals in Nuclear Medical Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Radiopharmaceuticals in Nuclear Medical Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Radiopharmaceuticals in Nuclear Medical Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Radiopharmaceuticals in Nuclear Medical Estimates and Projections (2015-2026)
2.4.2 Europe Radiopharmaceuticals in Nuclear Medical Estimates and Projections (2015-2026)
2.4.3 China Radiopharmaceuticals in Nuclear Medical Estimates and Projections (2015-2026)
2.4.4 Japan Radiopharmaceuticals in Nuclear Medical Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Radiopharmaceuticals in Nuclear Medical Estimates and Projections (2015-2026)
2.4.6 India Radiopharmaceuticals in Nuclear Medical Estimates and Projections (2015-2026)
3 Global Radiopharmaceuticals in Nuclear Medical Competition Landscape by Players
3.1 Global Top Radiopharmaceuticals in Nuclear Medical Players by Sales (2015-2020)
3.2 Global Top Radiopharmaceuticals in Nuclear Medical Players by Revenue (2015-2020)
3.3 Global Radiopharmaceuticals in Nuclear Medical Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Radiopharmaceuticals in Nuclear Medical as of 2019)
3.4 Global Radiopharmaceuticals in Nuclear Medical Average Price by Company (2015-2020)
3.5 Manufacturers Radiopharmaceuticals in Nuclear Medical Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Radiopharmaceuticals in Nuclear Medical Players (Opinion Leaders)
4 Global Radiopharmaceuticals in Nuclear Medical Market Size by Type
4.1 Global Radiopharmaceuticals in Nuclear Medical Historic Market Review by Type (2015-2020)
4.1.1 Global Radiopharmaceuticals in Nuclear Medical Sales Market Share by Type (2015-2020)
4.1.2 Global Radiopharmaceuticals in Nuclear Medical Revenue Market Share by Type (2015-2020)
4.1.3 Global Radiopharmaceuticals in Nuclear Medical Price by Type (2015-2020)
4.2 Global Radiopharmaceuticals in Nuclear Medical Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Radiopharmaceuticals in Nuclear Medical Sales Forecast by Type (2021-2026)
4.2.2 Global Radiopharmaceuticals in Nuclear Medical Revenue Forecast by Type (2021-2026)
4.2.3 Global Radiopharmaceuticals in Nuclear Medical Price Forecast by Type (2021-2026)
5 Global Radiopharmaceuticals in Nuclear Medical Market Size by Application
5.1 Global Radiopharmaceuticals in Nuclear Medical Historic Market Review by Application (2015-2020)
5.1.1 Global Radiopharmaceuticals in Nuclear Medical Sales Market Share by Application (2015-2020)
5.1.2 Global Radiopharmaceuticals in Nuclear Medical Revenue Market Share by Application (2015-2020)
5.1.3 Global Radiopharmaceuticals in Nuclear Medical Price by Application (2015-2020)
5.2 Global Radiopharmaceuticals in Nuclear Medical Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Radiopharmaceuticals in Nuclear Medical Sales Forecast by Application (2021-2026)
5.2.2 Global Radiopharmaceuticals in Nuclear Medical Revenue Forecast by Application (2021-2026)
5.2.3 Global Radiopharmaceuticals in Nuclear Medical Price Forecast by Application (2021-2026)
6 United States Radiopharmaceuticals in Nuclear Medical Market Facts & Figures
6.1 United States Radiopharmaceuticals in Nuclear Medical Sales Market Share by Company (2015-2020)
6.2 United States Radiopharmaceuticals in Nuclear Medical Sales Market Share by Type (2015-2020)
6.3 United States Radiopharmaceuticals in Nuclear Medical Sales Market Share by Application (2015-2020)
7 Europe Radiopharmaceuticals in Nuclear Medical Market Facts & Figures
7.1 Europe Radiopharmaceuticals in Nuclear Medical Sales Market Share by Company (2015-2020)
7.2 Europe Radiopharmaceuticals in Nuclear Medical Sales Market Share by Type (2015-2020)
7.3 Europe Radiopharmaceuticals in Nuclear Medical Sales Market Share by Application (2015-2020)
8 China Radiopharmaceuticals in Nuclear Medical Market Facts & Figures
8.1 China Radiopharmaceuticals in Nuclear Medical Sales Market Share by Company (2015-2020)
8.2 China Radiopharmaceuticals in Nuclear Medical Sales Market Share by Type (2015-2020)
8.3 China Radiopharmaceuticals in Nuclear Medical Sales Market Share by Application (2015-2020)
9 Japan Radiopharmaceuticals in Nuclear Medical Market Facts & Figures
9.1 Japan Radiopharmaceuticals in Nuclear Medical Sales Market Share by Company (3015-3030)
9.2 Japan Radiopharmaceuticals in Nuclear Medical Sales Market Share by Type (2015-2020)
9.3 Japan Radiopharmaceuticals in Nuclear Medical Sales Market Share by Application (2015-2020)
10 Southeast Asia Radiopharmaceuticals in Nuclear Medical Market Facts & Figures
10.1 Southeast Asia Radiopharmaceuticals in Nuclear Medical Sales Market Share by Company (2015-2020)
10.2 Southeast Asia Radiopharmaceuticals in Nuclear Medical Sales Market Share by Type (2015-2020)
10.3 Southeast Asia Radiopharmaceuticals in Nuclear Medical Sales Market Share by Application (2015-2020)
11 India Radiopharmaceuticals in Nuclear Medical Market Facts & Figures
11.1 India Radiopharmaceuticals in Nuclear Medical Sales Market Share by Company (2015-2020)
11.2 India Radiopharmaceuticals in Nuclear Medical Sales Market Share by Type (2015-2020)
11.3 India Radiopharmaceuticals in Nuclear Medical Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Radiopharmaceuticals in Nuclear Medical Business
12.1 Bracco Imaging
12.1.1 Bracco Imaging Corporation Information
12.1.2 Bracco Imaging Business Overview
12.1.3 Bracco Imaging Radiopharmaceuticals in Nuclear Medical Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Bracco Imaging Radiopharmaceuticals in Nuclear Medical Products Offered
12.1.5 Bracco Imaging Recent Development
12.2 Cambridge Isotope Laboratories
12.2.1 Cambridge Isotope Laboratories Corporation Information
12.2.2 Cambridge Isotope Laboratories Business Overview
12.2.3 Cambridge Isotope Laboratories Radiopharmaceuticals in Nuclear Medical Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Cambridge Isotope Laboratories Radiopharmaceuticals in Nuclear Medical Products Offered
12.2.5 Cambridge Isotope Laboratories Recent Development
12.3 Cardinal Health
12.3.1 Cardinal Health Corporation Information
12.3.2 Cardinal Health Business Overview
12.3.3 Cardinal Health Radiopharmaceuticals in Nuclear Medical Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Cardinal Health Radiopharmaceuticals in Nuclear Medical Products Offered
12.3.5 Cardinal Health Recent Development
12.4 Medtronic
12.4.1 Medtronic Corporation Information
12.4.2 Medtronic Business Overview
12.4.3 Medtronic Radiopharmaceuticals in Nuclear Medical Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Medtronic Radiopharmaceuticals in Nuclear Medical Products Offered
12.4.5 Medtronic Recent Development
12.5 Eczacibasi-Monrol
12.5.1 Eczacibasi-Monrol Corporation Information
12.5.2 Eczacibasi-Monrol Business Overview
12.5.3 Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medical Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medical Products Offered
12.5.5 Eczacibasi-Monrol Recent Development
12.6 Fujifilm Holdings Corporation
12.6.1 Fujifilm Holdings Corporation Corporation Information
12.6.2 Fujifilm Holdings Corporation Business Overview
12.6.3 Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medical Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medical Products Offered
12.6.5 Fujifilm Holdings Corporation Recent Development
12.7 GE Healthcare (Subsidiary Of General Electric Company)
12.7.1 GE Healthcare (Subsidiary Of General Electric Company) Corporation Information
12.7.2 GE Healthcare (Subsidiary Of General Electric Company) Business Overview
12.7.3 GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medical Sales, Revenue and Gross Margin (2015-2020)
12.7.4 GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medical Products Offered
12.7.5 GE Healthcare (Subsidiary Of General Electric Company) Recent Development
12.8 IBA Group
12.8.1 IBA Group Corporation Information
12.8.2 IBA Group Business Overview
12.8.3 IBA Group Radiopharmaceuticals in Nuclear Medical Sales, Revenue and Gross Margin (2015-2020)
12.8.4 IBA Group Radiopharmaceuticals in Nuclear Medical Products Offered
12.8.5 IBA Group Recent Development
12.9 Lantheus Medical Imaging
12.9.1 Lantheus Medical Imaging Corporation Information
12.9.2 Lantheus Medical Imaging Business Overview
12.9.3 Lantheus Medical Imaging Radiopharmaceuticals in Nuclear Medical Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Lantheus Medical Imaging Radiopharmaceuticals in Nuclear Medical Products Offered
12.9.5 Lantheus Medical Imaging Recent Development
12.10 Nordion
12.10.1 Nordion Corporation Information
12.10.2 Nordion Business Overview
12.10.3 Nordion Radiopharmaceuticals in Nuclear Medical Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Nordion Radiopharmaceuticals in Nuclear Medical Products Offered
12.10.5 Nordion Recent Development
12.11 Ntp Radioisotopes
12.11.1 Ntp Radioisotopes Corporation Information
12.11.2 Ntp Radioisotopes Business Overview
12.11.3 Ntp Radioisotopes Radiopharmaceuticals in Nuclear Medical Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Ntp Radioisotopes Radiopharmaceuticals in Nuclear Medical Products Offered
12.11.5 Ntp Radioisotopes Recent Development
12.12 Siemens Healthcare
12.12.1 Siemens Healthcare Corporation Information
12.12.2 Siemens Healthcare Business Overview
12.12.3 Siemens Healthcare Radiopharmaceuticals in Nuclear Medical Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Siemens Healthcare Radiopharmaceuticals in Nuclear Medical Products Offered
12.12.5 Siemens Healthcare Recent Development
12.13 Taiyo Nippon Sanso Corporation
12.13.1 Taiyo Nippon Sanso Corporation Corporation Information
12.13.2 Taiyo Nippon Sanso Corporation Business Overview
12.13.3 Taiyo Nippon Sanso Corporation Radiopharmaceuticals in Nuclear Medical Sales, Revenue and Gross Margin (2015-2020)
12.13.4 Taiyo Nippon Sanso Corporation Radiopharmaceuticals in Nuclear Medical Products Offered
12.13.5 Taiyo Nippon Sanso Corporation Recent Development
12.14 Urenco Limited
12.14.1 Urenco Limited Corporation Information
12.14.2 Urenco Limited Business Overview
12.14.3 Urenco Limited Radiopharmaceuticals in Nuclear Medical Sales, Revenue and Gross Margin (2015-2020)
12.14.4 Urenco Limited Radiopharmaceuticals in Nuclear Medical Products Offered
12.14.5 Urenco Limited Recent Development
12.15 Rotem Industries
12.15.1 Rotem Industries Corporation Information
12.15.2 Rotem Industries Business Overview
12.15.3 Rotem Industries Radiopharmaceuticals in Nuclear Medical Sales, Revenue and Gross Margin (2015-2020)
12.15.4 Rotem Industries Radiopharmaceuticals in Nuclear Medical Products Offered
12.15.5 Rotem Industries Recent Development
13 Radiopharmaceuticals in Nuclear Medical Manufacturing Cost Analysis
13.1 Radiopharmaceuticals in Nuclear Medical Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Radiopharmaceuticals in Nuclear Medical
13.4 Radiopharmaceuticals in Nuclear Medical Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Radiopharmaceuticals in Nuclear Medical Distributors List
14.3 Radiopharmaceuticals in Nuclear Medical Customers
15 Market Dynamics
15.1 Radiopharmaceuticals in Nuclear Medical Market Trends
15.2 Radiopharmaceuticals in Nuclear Medical Opportunities and Drivers
15.3 Radiopharmaceuticals in Nuclear Medical Market Challenges
15.4 Radiopharmaceuticals in Nuclear Medical Market Restraints
15.5 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Radiopharmaceuticals in Nuclear Medical Sales (K MT) Growth Rate by Type (2020-2026) (US$ Million)
Table 2. Global Radiopharmaceuticals in Nuclear Medical Sales (K MT) Comparison by Application (2020-2026) (US$ Million)
Table 3. Global Market Radiopharmaceuticals in Nuclear Medical Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Radiopharmaceuticals in Nuclear Medical Sales (K MT) by Region (2015-2020)
Table 5. Global Radiopharmaceuticals in Nuclear Medical Sales Market Share by Region (2015-2020)
Table 6. Global Radiopharmaceuticals in Nuclear Medical Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Radiopharmaceuticals in Nuclear Medical Revenue Share by Region (2015-2020)
Table 8. Global Radiopharmaceuticals in Nuclear Medical Sales (K MT) Forecast by Region (2021-2026)
Table 9. Global Radiopharmaceuticals in Nuclear Medical Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Radiopharmaceuticals in Nuclear Medical Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Radiopharmaceuticals in Nuclear Medical Revenue Share Forecast by Region (2021-2026)
Table 12. Global Radiopharmaceuticals in Nuclear Medical (K MT) of Key Companies (2015-2020)
Table 13. Global Radiopharmaceuticals in Nuclear Medical Sales Share by Company (2015-2020)
Table 14. Global Radiopharmaceuticals in Nuclear Medical Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Radiopharmaceuticals in Nuclear Medical Revenue Share by Company (2015-2020)
Table 16. Global Radiopharmaceuticals in Nuclear Medical by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Radiopharmaceuticals in Nuclear Medical as of 2019)
Table 17. Global Radiopharmaceuticals in Nuclear Medical Average Price (USD/MT) of Key Company (2015-2020)
Table 18. Manufacturers Radiopharmaceuticals in Nuclear Medical Manufacturing Sites and Area Served
Table 19. Manufacturers Radiopharmaceuticals in Nuclear Medical Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Radiopharmaceuticals in Nuclear Medical Players
Table 22. Global Radiopharmaceuticals in Nuclear Medical Sales (K MT) by Type (2015-2020)
Table 23. Global Radiopharmaceuticals in Nuclear Medical Sales Share by Type (2015-2020)
Table 24. Global Radiopharmaceuticals in Nuclear Medical Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Radiopharmaceuticals in Nuclear Medical Price (K MT) by Type (2015-2020)
Table 26. Global Radiopharmaceuticals in Nuclear Medical Sales Share by Type (2021-2026)
Table 27. Global Radiopharmaceuticals in Nuclear Medical Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Radiopharmaceuticals in Nuclear Medical Revenue Share by Type (2021-2026)
Table 29. Global Radiopharmaceuticals in Nuclear Medical Price (K MT) by Type (2021-2026)
Table 30. Global Radiopharmaceuticals in Nuclear Medical Sales (K MT) by Application (2015-2020)
Table 31. Global Radiopharmaceuticals in Nuclear Medical Sales Share by Application (2015-2020)
Table 32. Global Radiopharmaceuticals in Nuclear Medical Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Radiopharmaceuticals in Nuclear Medical Price (K MT) by Application (2015-2020)
Table 34. Global Radiopharmaceuticals in Nuclear Medical Sales (K MT) by Application (2021-2026)
Table 35. Global Radiopharmaceuticals in Nuclear Medical Sales Share by Application (2021-2026)
Table 36. Global Radiopharmaceuticals in Nuclear Medical Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Radiopharmaceuticals in Nuclear Medical Revenue Share by Application (2021-2026)
Table 38. Global Radiopharmaceuticals in Nuclear Medical Price (K MT) by Application (2021-2026)
Table 39. United States Radiopharmaceuticals in Nuclear Medical Sales (K MT) by Company (2015-2020)
Table 40. United States Radiopharmaceuticals in Nuclear Medical Sales Market Share by Company (2015-2020)
Table 41. United States Radiopharmaceuticals in Nuclear Medical Sales (K MT) by Type (2015-2020)
Table 42. United States Radiopharmaceuticals in Nuclear Medical Sales Market Share by Type (2015-2020)
Table 43. United States Radiopharmaceuticals in Nuclear Medical Sales (K MT) by Application (2015-2020)
Table 44. United States Radiopharmaceuticals in Nuclear Medical Sales Market Share by Application (2015-2020)
Table 45. Europe Radiopharmaceuticals in Nuclear Medical Sales (K MT) by Company (2015-2020)
Table 46. Europe Radiopharmaceuticals in Nuclear Medical Sales Market Share by Company (2015-2020)
Table 47. Europe Radiopharmaceuticals in Nuclear Medical Sales (K MT) by Type (2015-2020)
Table 48. Europe Radiopharmaceuticals in Nuclear Medical Sales Market Share by Type (2015-2020)
Table 49. Europe Radiopharmaceuticals in Nuclear Medical Sales (K MT) by Application (2015-2020)
Table 50. Europe Radiopharmaceuticals in Nuclear Medical Sales Market Share by Type (2015-2020)
Table 51. China Radiopharmaceuticals in Nuclear Medical Sales (K MT) by Company (2015-2020)
Table 52. China Radiopharmaceuticals in Nuclear Medical Sales Market Share by Company (2015-2020)
Table 53. China Radiopharmaceuticals in Nuclear Medical Sales (K MT) by Type (2015-2020)
Table 54. China Radiopharmaceuticals in Nuclear Medical Sales Market Share by Type (2015-2020)
Table 55. China Radiopharmaceuticals in Nuclear Medical Sales (K MT) by Application (2015-2020)
Table 56. China Radiopharmaceuticals in Nuclear Medical Sales Market Share by Application (2015-2020)
Table 57. Japan Radiopharmaceuticals in Nuclear Medical Sales (K MT) by Company (2015-2020)
Table 58. Japan Radiopharmaceuticals in Nuclear Medical Sales Market Share by Company (2015-2020)
Table 59. Japan Radiopharmaceuticals in Nuclear Medical Sales (K MT) by Type (2015-2020)
Table 60. Japan Radiopharmaceuticals in Nuclear Medical Sales Market Share by Type (2015-2020)
Table 61. Japan Radiopharmaceuticals in Nuclear Medical Sales (K MT) by Application (2015-2020)
Table 62. Japan Radiopharmaceuticals in Nuclear Medical Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Radiopharmaceuticals in Nuclear Medical Sales (K MT) by Company (2015-2020)
Table 64. Southeast Asia Radiopharmaceuticals in Nuclear Medical Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Radiopharmaceuticals in Nuclear Medical Sales (K MT) by Type (2015-2020)
Table 66. Southeast Asia Radiopharmaceuticals in Nuclear Medical Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Radiopharmaceuticals in Nuclear Medical Sales (K MT) by Type (2015-2020)
Table 68. Southeast Asia Radiopharmaceuticals in Nuclear Medical Sales Market Share by Application (2015-2020)
Table 69. India Radiopharmaceuticals in Nuclear Medical Sales (K MT) by Company (2015-2020)
Table 70. India Radiopharmaceuticals in Nuclear Medical Sales Market Share by Company (2015-2020)
Table 71. India Radiopharmaceuticals in Nuclear Medical Sales (K MT) by Type (2015-2020)
Table 72. India Radiopharmaceuticals in Nuclear Medical Sales Market Share by Type (2015-2020)
Table 73. India Radiopharmaceuticals in Nuclear Medical Sales (K MT) by Application (2015-2020)
Table 74. India Radiopharmaceuticals in Nuclear Medical Sales Market Share by Application (2015-2020)
Table 75. Bracco Imaging Corporation Information
Table 76. Bracco Imaging Description and Business Overview
Table 77. Bracco Imaging Radiopharmaceuticals in Nuclear Medical Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 78. Bracco Imaging Radiopharmaceuticals in Nuclear Medical Product
Table 79. Bracco Imaging Recent Development
Table 80. Cambridge Isotope Laboratories Corporation Information
Table 81. Cambridge Isotope Laboratories Description and Business Overview
Table 82. Cambridge Isotope Laboratories Radiopharmaceuticals in Nuclear Medical Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 83. Cambridge Isotope Laboratories Radiopharmaceuticals in Nuclear Medical Product
Table 84. Cambridge Isotope Laboratories Recent Development
Table 85. Cardinal Health Corporation Information
Table 86. Cardinal Health Description and Business Overview
Table 87. Cardinal Health Radiopharmaceuticals in Nuclear Medical Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 88. Cardinal Health Radiopharmaceuticals in Nuclear Medical Product
Table 89. Cardinal Health Recent Development
Table 90. Medtronic Corporation Information
Table 91. Medtronic Description and Business Overview
Table 92. Medtronic Radiopharmaceuticals in Nuclear Medical Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 93. Medtronic Radiopharmaceuticals in Nuclear Medical Product
Table 94. Medtronic Recent Development
Table 95. Eczacibasi-Monrol Corporation Information
Table 96. Eczacibasi-Monrol Description and Business Overview
Table 97. Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medical Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 98. Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medical Product
Table 99. Eczacibasi-Monrol Recent Development
Table 100. Fujifilm Holdings Corporation Corporation Information
Table 101. Fujifilm Holdings Corporation Description and Business Overview
Table 102. Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medical Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 103. Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medical Product
Table 104. Fujifilm Holdings Corporation Recent Development
Table 105. GE Healthcare (Subsidiary Of General Electric Company) Corporation Information
Table 106. GE Healthcare (Subsidiary Of General Electric Company) Description and Business Overview
Table 107. GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medical Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 108. GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medical Product
Table 109. GE Healthcare (Subsidiary Of General Electric Company) Recent Development
Table 110. IBA Group Corporation Information
Table 111. IBA Group Radiopharmaceuticals in Nuclear Medical Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 112. IBA Group Description and Business Overview
Table 113. IBA Group Radiopharmaceuticals in Nuclear Medical Product
Table 114. IBA Group Recent Development
Table 115. Lantheus Medical Imaging Corporation Information
Table 116. Lantheus Medical Imaging Radiopharmaceuticals in Nuclear Medical Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 117. Lantheus Medical Imaging Description and Business Overview
Table 118. Lantheus Medical Imaging Radiopharmaceuticals in Nuclear Medical Product
Table 119. Lantheus Medical Imaging Recent Development
Table 120. Nordion Corporation Information
Table 121. Nordion Description and Business Overview
Table 122. Nordion Radiopharmaceuticals in Nuclear Medical Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 123. Nordion Radiopharmaceuticals in Nuclear Medical Product
Table 124. Nordion Recent Development
Table 125. Ntp Radioisotopes Corporation Information
Table 126. Ntp Radioisotopes Description and Business Overview
Table 127. Ntp Radioisotopes Radiopharmaceuticals in Nuclear Medical Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 128. Ntp Radioisotopes Radiopharmaceuticals in Nuclear Medical Product
Table 129. Ntp Radioisotopes Recent Development
Table 130. Siemens Healthcare Corporation Information
Table 131. Siemens Healthcare Description and Business Overview
Table 132. Siemens Healthcare Radiopharmaceuticals in Nuclear Medical Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 133. Siemens Healthcare Radiopharmaceuticals in Nuclear Medical Product
Table 134. Siemens Healthcare Recent Development
Table 135. Taiyo Nippon Sanso Corporation Corporation Information
Table 136. Taiyo Nippon Sanso Corporation Description and Business Overview
Table 137. Taiyo Nippon Sanso Corporation Radiopharmaceuticals in Nuclear Medical Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 138. Taiyo Nippon Sanso Corporation Radiopharmaceuticals in Nuclear Medical Product
Table 139. Taiyo Nippon Sanso Corporation Recent Development
Table 140. Urenco Limited Corporation Information
Table 141. Urenco Limited Description and Business Overview
Table 142. Urenco Limited Radiopharmaceuticals in Nuclear Medical Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 143. Urenco Limited Radiopharmaceuticals in Nuclear Medical Product
Table 144. Urenco Limited Recent Development
Table 145. Rotem Industries Corporation Information
Table 146. Rotem Industries Description and Business Overview
Table 147. Rotem Industries Radiopharmaceuticals in Nuclear Medical Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 148. Rotem Industries Radiopharmaceuticals in Nuclear Medical Product
Table 149. Rotem Industries Recent Development
Table 150. Production Base and Market Concentration Rate of Raw Material
Table 151. Key Suppliers of Raw Materials
Table 152. Radiopharmaceuticals in Nuclear Medical Distributors List
Table 153. Radiopharmaceuticals in Nuclear Medical Customers List
Table 154. Radiopharmaceuticals in Nuclear Medical Market Key Trends
Table 155. Radiopharmaceuticals in Nuclear Medical Key Opportunities and Drivers
Table 156. Radiopharmaceuticals in Nuclear Medical Market Challenges
Table 157. Research Programs/Design for This Report
Table 158. Key Data Information from Secondary Sources
Table 159. Key Data Information from Primary Sources
List of Figures
Figure 1. Radiopharmaceuticals in Nuclear Medical Product Picture
Figure 2. Global Radiopharmaceuticals in Nuclear Medical Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Radiopharmaceuticals in Nuclear Medical Market Share by Application in 2020 & 2026
Figure 6. Diagnostic Application Examples
Figure 7. Therapeutic Application Examples
Figure 8. Research Examples
Figure 9. Pharmaceutical Examples
Figure 10. Industrial Examples
Figure 11. Global Radiopharmaceuticals in Nuclear Medical Sales (K MT) Growth Rate (2015-2026)
Figure 12. Global Radiopharmaceuticals in Nuclear Medical Revenue (US$ Million) Growth Rate (2015-2026)
Figure 13. Global Radiopharmaceuticals in Nuclear Medical Price Trends Growth Rate (2015-2026) (USD/MT)
Figure 14. Global Radiopharmaceuticals in Nuclear Medical Revenue Market Share by Region: 2015 VS 2020
Figure 15. Global Radiopharmaceuticals in Nuclear Medical Revenue Market Share by Region: 2021 VS 2026
Figure 16. United States Radiopharmaceuticals in Nuclear Medical Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. United States Radiopharmaceuticals in Nuclear Medical Sales (K MT) Growth Rate (2015-2026)
Figure 18. Europe Radiopharmaceuticals in Nuclear Medical Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. Europe Radiopharmaceuticals in Nuclear Medical Sales (Million USD) Growth Rate (2015-2026)
Figure 20. China Radiopharmaceuticals in Nuclear Medical Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. China Radiopharmaceuticals in Nuclear Medical Sales (Million USD) and Growth Rate (2015-2026)
Figure 22. Japan Radiopharmaceuticals in Nuclear Medical Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Japan Radiopharmaceuticals in Nuclear Medical Sales (Million USD) Growth Rate (2015-2026)
Figure 24. Southeast Asia Radiopharmaceuticals in Nuclear Medical Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. Southeast Asia Radiopharmaceuticals in Nuclear Medical Sales (Million USD) Growth Rate (2015-2026)
Figure 26. India Radiopharmaceuticals in Nuclear Medical Revenue (Million USD) Growth Rate (2015-2026)
Figure 27. India Radiopharmaceuticals in Nuclear Medical Sales (Million USD) Growth Rate (2015-2026)
Figure 28. Global 5 Largest Radiopharmaceuticals in Nuclear Medical Players Market Share by Revenue in Radiopharmaceuticals in Nuclear Medical 2015 & 2019
Figure 29. Radiopharmaceuticals in Nuclear Medical Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 30. Global Radiopharmaceuticals in Nuclear Medical Revenue Share by Type (2015-2020)
Figure 31. Global Radiopharmaceuticals in Nuclear Medical Revenue Growth Rate by Type in 2015 & 2019
Figure 32. Global Radiopharmaceuticals in Nuclear Medical Revenue Share by Application (2015-2020)
Figure 33. Global Radiopharmaceuticals in Nuclear Medical Revenue Growth Rate by Application in 2015 & 2019
Figure 34. United States Radiopharmaceuticals in Nuclear Medical Sales Market Share by Type in 2019
Figure 35. United States Radiopharmaceuticals in Nuclear Medical Sales Market Share by Type in 2019
Figure 36. Europe Radiopharmaceuticals in Nuclear Medical Sales Market Share by Company in 2019
Figure 37. Europe Radiopharmaceuticals in Nuclear Medical Sales Market Share by Type in 2019
Figure 38. Europe Radiopharmaceuticals in Nuclear Medical Sales Market Share by Application in 2019
Figure 39. China Radiopharmaceuticals in Nuclear Medical Sales Market Share by Company in 2019
Figure 40. China Radiopharmaceuticals in Nuclear Medical Sales Market Share by Type in 2019
Figure 41. China Radiopharmaceuticals in Nuclear Medical Sales Market Share by Application in 2019
Figure 42. Japan Radiopharmaceuticals in Nuclear Medical Sales Market Share by Company in 2019
Figure 43. Japan Radiopharmaceuticals in Nuclear Medical Sales Market Share by Type in 2019
Figure 44. Japan Radiopharmaceuticals in Nuclear Medical Sales Market Share by Application in 2019
Figure 45. Southeast Asia Radiopharmaceuticals in Nuclear Medical Sales Market Share by Company in 2019
Figure 46. Southeast Asia Radiopharmaceuticals in Nuclear Medical Sales Market Share by Type in 2019
Figure 47. Southeast Asia Radiopharmaceuticals in Nuclear Medical Sales Market Share by Application in 2019
Figure 48. India Radiopharmaceuticals in Nuclear Medical Sales Market Share by Company in 2019
Figure 49. India Radiopharmaceuticals in Nuclear Medical Sales Market Share by Type in 2019
Figure 50. India Radiopharmaceuticals in Nuclear Medical Sales Market Share by Application in 2019
Figure 51. Key Raw Materials Price Trend
Figure 52. Manufacturing Cost Structure of Radiopharmaceuticals in Nuclear Medical
Figure 53. Manufacturing Process Analysis of Radiopharmaceuticals in Nuclear Medical
Figure 54. Radiopharmaceuticals in Nuclear Medical Industrial Chain Analysis
Figure 55. Channels of Distribution
Figure 56. Distributors Profiles
Figure 57. Porter's Five Forces Analysis
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
診断用放射性医薬品の世界市場レポート2020 Radiopharmaceuticals refer to a class of special medicines containing radionuclides for medical diagnosis and treatment. Compounds or biological preparations containing radionuclide labels used for medical diagnosis or treatment in the body. Diagnostic radiopharmaceuticals are radioisotopes that bin…- 核医学/放射性医薬品の世界市場レポート2020 Market Analysis and Insights: Global Nuclear Medicine/Radiopharmaceutic Market The global Nuclear Medicine/Radiopharmaceutic market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Nuclear Medicine/Radiopharmaceutic Scope and M…
- 核エネルギーの世界市場レポート2020 Nuclear power is the use of nuclear reactions that release nuclear energy to generate heat, which most frequently is then used in steam turbines to produce electricity in a nuclear power plant. Nuclear power can be obtained from nuclear fission, nuclear decay and nuclear fusion. Nuclear energy techn…
- 600MHz核磁気共鳴分光計の世界市場レポート2020 Nuclear magnetic resonance (NMR) spectrometer is the most powerful analytical tool currently available to an organic chemist. NMR allows characterization of a very small amount of sample (10mg), and does not destroy the sample (non-destructive technique). NMR spectra can provide vast information abo…
- 核医学治療の世界市場レポート2020 Radioactive material, called radiopharmaceuticals, can be used to treat certain conditions. This is called nuclear medicine therapy. Therapeutic nuclear medicines are a pharmaceutical formulation that consists of radioactive substances (radioisotopes). Therapeutic nuclear medicines are intending for…